Clinical trial
Canadian Fabry Disease Initiative (CFDI) National Registry
NCT00455104 · Canadian Fabry Research Consortium, Other · Recruiting
Key facts
| NCT number | NCT00455104 |
|---|---|
| Title | Canadian Fabry Disease Initiative (CFDI) National Registry |
| Official title | Canadian Fabry Disease Initiative National Registry: Outcomes of Rare Disease Therapeutics and Cardiovascular Risk Factor Modification |
| Acronym | CFDI-NR |
| Lead sponsor | Canadian Fabry Research Consortium, Other |
| Collaborators | Nova Scotia Health Authority |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Fabry Disease |
| Intervention type | Other |
| Interventions | No intervention |
| Enrollment | 600 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2029 |
| Completion | Oct 1, 2029 |
| First posted | Apr 3, 2007 |
| Last update posted | Feb 15, 2024 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: